BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

ELIXIR LABS, INC. — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Termination

ELIXIR LABS, INC.

via TERRAPIN STRATEGY, INC

3rd Quarter (July 1 - Sep 30) · 2024Posted Oct 11, 2024Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: ELIXIR LABS, INC.
Description: AI
Location: Maryland · United States of America

Registrant

Firm: TERRAPIN STRATEGY, INC
Location: Arlington, Virginia, United States of America

Lobbying activities

1 issue

Government Issues
GSA Multiple Award Schedule
Lobbyistsmr JASON JACKSON FRYE
Covered position (mr JASON JACKSON FRYE): Tom Emmer MN 06 LD

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.